Company Overview of Phibro Animal Health Corporation
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also include antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic inte...
Glenpointe Centre East
300 Frank West Burr Boulevard
Teaneck, NJ 07666
Key Executives for Phibro Animal Health Corporation
Chairman, Chief Executive Officer, President and Member of Compensation Committee
Total Annual Compensation: $2.5M
Chief Financial Officer
Total Annual Compensation: $664.7K
Chief Operating Officer
Total Annual Compensation: $652.7K
Compensation as of Fiscal Year 2016.
Phibro Animal Health Corporation Key Developments
Phibro Animal Health Corporation Reports Consolidated Earnings Results for the Third Quarter Ended September 30, 2016; Provides Earnings Guidance for the Full Year of 2016; Reaffirms Earnings Guidance for the Full Year of 2017
Nov 9 16
Phibro Animal Health Corporation reported consolidated earnings results for the third quarter ended September 30, 2016. For the quarter, the company reported net sales of $188 million, operating income of $21.8 million, income before income taxes of $17.6 million, net income of $12.2 million or $0.31 per diluted share against net sales of $187.1 million, operating income of $21.9 million, income before income taxes of $23.5 million, net income of $18.8 million or $0.47 per diluted share a year ago. EBITDA of $27.8 million and adjusted EBITDA of $29.8 million against EBITDA of $32.7 million and adjusted EBITDA of $27.7 million a year ago. Adjusted net income of $14.6 million compared to $13.8 million a year ago. Net cash provided by operating activities of $21.5 million compared to net cash used in operating activities of $2.4 million a year ago. Capital expenditures were $5.9 million compared to $8.1 million a year ago. The decrease in net income was a result of the factors, including a $5.8 million decline in foreign currency (gains) losses, net and a $0.7 million increase in income tax expense.
For the full year of 2016, the company expects net sales to be $752 million, adjusted EBITDA to be $114 million, operating income to be $96 million, income before income taxes to be $81 million, net income to be $57 million or $1.43 per diluted share. The company maintained full year CapEx guidance of $30 million.
For the full year of 2017, the company reaffirms net sales to be $750 million to $770 million, adjusted EBITDA to be in the range of $116 million to $120 million, operating income to be $95 million to $99 million, income before income taxes to be $78 million to $82 million, net income to be $55 million to $58 million or $1.38 to $1.45 per diluted share.
Phibro Animal Health Corporation Declares Quarterly Dividend, Payable on December 21, 2016
Nov 7 16
The Board of Directors of Phibro Animal Health Corporation declared a quarterly cash dividend of $0.10 per share on its Class A common stock and Class B common stock, payable on December 21, 2016, to stockholders of record at the close of business on November 30, 2016.
Phibro Animal Health Corporation to Report Q1, 2017 Results on Nov 09, 2016
Oct 5 16
Phibro Animal Health Corporation announced that they will report Q1, 2017 results at 5:00 PM, Eastern Standard Time on Nov 09, 2016
Similar Private Companies By Industry
Recent Private Companies Transactions